Digest Network Come funziona
Network
/
Società
Bi
Non verificato

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

34 comunicati stampa

Guarda tutti i comunicati
02/09/2026
Mercato del lavoro
Salute
Biotecnologia
Scienza
Farmaceutica
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
02/09/2026
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
29/06/2026
Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
29/06/2026
Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
15/06/2026
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
15/06/2026
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
01/04/2026
Mercato del lavoro
Industria
Scienza
Fitness
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
01/04/2026
Mercato del lavoro
Industria
Salute
Tecnica
Biotecnologia
Fitness
Farmaceutica
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
30/03/2026
Mercato del lavoro
Industria
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0
30/03/2026
Mercato del lavoro
Industria
Salute
Biotecnologia
Scienza
Farmaceutica
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
Fonte
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0